Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -674.48% | -225.00% | -174.87% | -2,362.05% | -300.62% |
| Total Depreciation and Amortization | -31.55% | -14.81% | 6.19% | 8.79% | 8.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 654.50% | 204.76% | -69.53% | 485.78% | -48.06% |
| Change in Net Operating Assets | -51.11% | 86.44% | -8.26% | -28.69% | 670.83% |
| Cash from Operations | -72.80% | 150.24% | -92.37% | -6.69% | 33.52% |
| Capital Expenditure | 68.67% | 29.68% | 27.99% | 40.88% | 1.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.92% | -101.79% | -3,598.12% | 79.01% | -3,195.41% |
| Cash from Investing | -17.79% | -109.23% | -734.13% | 74.53% | -701.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -120.60% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -8,200.00% | 55.15% | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -4,050.00% | -60.04% | 200.00% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -524.45% | -96.18% | -2,352.72% | 58.07% | -129.74% |